AP
EBS icon

AHL Partners’s Emergent Biosolutions EBS Stock Holding History

AHL Partners’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$853K Sell
18,351
-61,531
-77% -$2.59M 0.01% 928
2017
Q3 		$3.23M Buy
+79,882
New +$2.89M 0.06% 520
2016
Q4 		– Sell
-18,675
Closed -$588K – 1070
2016
Q3 		$588K Sell
18,675
-8,249
-31% -$240K 0.02% 777
2016
Q2 		$757K Buy
+26,924
New +$1.06M 0.04% 507

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AHL Partners's EBS Position: Q4 2017 in Review

AHL Partners reduced its Emergent Biosolutions (EBS) stake by 77% in Q4 2017, selling an estimated $2.59M and leaving 18,351 shares worth $853K. The position accounts for 0.01% of the portfolio, ranked #928.

AHL Partners first reported a position in EBS in Q2 2016 and has held it in 4 quarters since. The position peaked at $3.23M in Q3 2017. 238 funds tracked by Wall St. Rank hold EBS as of Q4 2017.

  • AHL Partners held 18,351 shares of Emergent Biosolutions worth $853K as of Q4 2017.
  • AHL Partners sold 61,531 Emergent Biosolutions shares in Q4 2017, an estimated $2.59M.
  • Emergent Biosolutions made up 0.01% of AHL Partners's portfolio in Q4 2017, its #928 holding.
  • AHL Partners first reported a position in Emergent Biosolutions in Q2 2016 and has held it in 4 quarters since.
  • AHL Partners's Emergent Biosolutions position peaked at $3.23M in Q3 2017.
  • 238 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.